NuvaRing Side Effects Injury Lawsuits. The NuvaRing injury lawyers at our firm are currently investigating injuries caused by NuvaRing, a hormonal contraceptive manufactured by Organon. Our NuvaRing injury lawyers are representing a number of women who suffered blood clots, strokes and other cardiac side effects as a result of ‘NuvaRing’ use. Our ‘NuvaRing’ injury lawsuit lawyers are committed to making sure Organon is held accountable for the injuries caused by this defective contraceptive.
Parker Waichman LLP Defective Drug Lawyers
Since being approved by the Food and Drug Administration (FDA) in 2001, NuvaRing has been associated with a number of serious side effects, including blood clots, strokes and pulmonary embolism. Our ‘NuvaRing’ injury lawyers allege that the high number of injuries associated with ‘NuvaRing’ is the result of a dangerous type of hormone emitted by the device.
NuvaRing Side Effects
NuvaRing is a once-a-month contraceptive that consists of a small plastic ring that is inserted into the vagina and remains there for a three week period. ‘NuvaRing’ works by releasing hormones that prevent pregnancy from occurring. All hormonal contraceptives carry some risk of cardiac side effects. ‘NuvaRing’ side effect reports include incidences blood clots, strokes, heart attacks, pulmonary embolism and death.
NuvaRing releases a combination of ethinyl estradiol, a form of the hormone estrogen, and etonogestral. Etonogestral is an active metabolite of desogestrel, a form of the hormone progestin. In 2003 the New England Journal of Medicine published two studies that concluded that the use of low-estrogen oral contraceptives containing the progestin desogestrel significantly increases the risk of venous thromboembolism, a potentially fatal type of blood clot, more than low-estrogen birth control pills containing levonorgestrel. Our ‘NuvaRing’ injury lawyers believe that the presence of the active desogestral metabolite etonogestral places ‘NuvaRing’ users at a similarly high risk of venous thrombolembolsims, as well as other serious cardiac side effects.
In 2007, the consumer advocacy group Public Citizen asked the FDA to ban oral contraceptives that contained forms of desogestral because this dangerous progestin has been implicated in a higher risk of strokes, blood clots and other cardiovascular problems. ‘NuvaRing’ releases approximately 120 micrograms of etonogestral – an active desogestral metabolite – per day, a relatively high dose of this dangerous hormone. The ‘NuvaRing’ injury lawyers at our firm believe this high dose of etonogestral is responsible for the high number of cardiac side effects reports associated with ‘NuvaRing’.
Organon’s Misleading NuvaRing Side Effect Claims
Organon’s promotional literature for NuvaRing states that the dose of hormones released by the device is and that it has a low incidence of side effects, such as headaches, nausea, and breast tenderness that is similar to oral contraceptives. Our ‘NuvaRing’ injury lawyers have determined that Organon’s promotional claims are misleading, as the hormone formulation used in ‘NuvaRing’ exposes users to an unnecessarily high risk of strokes, blood clots and other cardiovascular problems.
The labeling for ‘NuvaRing’ does include some warnings regarding these dangerous cardiac side effects, but none of these warnings are emphasized and this could lead many ‘NuvaRing’ users to believe that this device carries similar risks to oral contraceptives. The ‘NuvaRing’ injury lawyers at our firm have determined that this is not the case, and that ‘NuvaRing’ exposes women to a higher risk of cardiac side effects than oral contraceptives. Lawsuits allege that Organon’s failure to highlight the higher cardiac risks posed by ‘NuvaRing’ constitutes negligence on the part of the drug maker.